Opko Financial Statements From 2010 to 2026

OPK Stock  USD 1.28  0.02  1.54%   
Analyzing historical trends in various income statement and balance sheet accounts from Opko Health's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Opko Health's valuation are summarized below:
Opko Health does not presently have any trending fundamental ratios for analysis.
Check Opko Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Opko Health's main balance sheet or income statement drivers, such as , as well as many indicators such as . Opko financial statements analysis is a perfect complement when working with Opko Health Valuation or Volatility modules.
Check out the analysis of Opko Health Correlation against competitors.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.

Opko Health Company Return On Equity Analysis

Opko Health's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Opko Health Return On Equity

    
  -0.13  
Most of Opko Health's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Opko Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Opko Health has a Return On Equity of -0.1332. This is 99.44% lower than that of the Biotechnology sector and 98.01% lower than that of the Health Care industry. The return on equity for all United States stocks is 57.03% lower than that of the firm.

Opko Health Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Opko Health's current stock value. Our valuation model uses many indicators to compare Opko Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Opko Health competition to find correlations between indicators driving Opko Health's intrinsic value. More Info.
Opko Health is regarded second in return on equity category among its peers. It is regarded fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Opko Health by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

About Opko Health Financial Statements

Opko Health investors utilize fundamental indicators, such as revenue or net income, to predict how Opko Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company was founded in 1991 and is headquartered in Miami, Florida. Opko Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 5767 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:
Check out the analysis of Opko Health Correlation against competitors.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.